Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-031589

SVP & Chief Scientific Officer sold 3,435 shares at $83.39 ($286,445)

From the SEC's structured data for this filing

Trades in this filing

Doberstein Stephen K · SVP & Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-05-16 Sale : show line 1 in the form −3,435 $83.39 $286,445 63,959 D
Open-market sales · 3,435 sh · avg $83.39 · $286,445
Loading xslF345X03/doc4.xml…